SASH3

Across TCGA pan-cancer cohorts, SASH3 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of SASH3’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where SASH3 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types SASH3 is over-expressed in tumor, although a few such as LSCC and COAD show the opposite, repressed pattern.

CCRCC, HNSC, and LSCC are the cancer types where SASH3 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SASH3 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	IV	+1.081	<.001	11	view →
HNSC	All	All	+0.259	<.001	7	view →
LSCC	Male	II,III,IV	−0.225	<.001	6	view →
COAD	All	III,IV	−0.212	.002	6	view →
PDAC	All	IV	−1.077	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

SASH3–CCRCC

Open the CCRCC breakdown →